TITLE

A glimpse into the black box of cost-effectiveness analyses

AUTHOR(S)
John-Baptiste, Ava A.; Bell, Chaim
PUB. DATE
April 2011
SOURCE
CMAJ: Canadian Medical Association Journal;4/5/2011, Vol. 183 Issue 6, pE307
SOURCE TYPE
Academic Journal
DOC. TYPE
Opinion
ABSTRACT
In this article, the author discusses the role of cost-effectiveness analyses on health policy. The author talks on a systematic review of cost-effectiveness analyses by N.P. Polyzos and colleagues evaluating cervical cancer screening methods wherein results show consistent underestimation of the diagnostic qualities of Papanicolau (Pap) test. She adds that the findings indicate that health policies are not sufficient to minimize bias and must motivate medical journals to improve peer review.
ACCESSION #
60159763

 

Related Articles

  • How do systematic reviews incorporate risk of bias assessments into the synthesis of evidence? A methodological study. Katikireddi, Srinivasa Vittal; Egan, Matt; Petticrew, Mark // Journal of Epidemiology & Community Health;Feb2015, Vol. 69 Issue 2, p189 

    Background: Systematic reviews (SRs) are expected to critically appraise included studies and privilege those at lowest risk of bias (RoB) in the synthesis. This study examines if and how critical appraisals inform the synthesis and interpretation of evidence in SRs. Methods: All SRs published...

  • Factors Affecting Compliance with Clinical Practice Guidelines for Pap Smear Screening among Healthcare Providers in Africa: Systematic Review and Meta-Summary of 2045 Individuals. Asonganyi, Etienne; Vaghasia, Meenakshi; Rodrigues, Clarissa; Phadtare, Amruta; Ford, Anne; Pietrobon, Ricardo; Atashili, Julius; Lynch, Catherine // PLoS ONE;Sep2013, Vol. 8 Issue 9, p1 

    Background:Although the importance of the Pap smear in reducing cancer incidence and mortality is known, many countries in Africa have not initiated yet widespread national cervical cancer screening programs. The World Health Organization (WHO) has published Clinical Practice Guidelines (CPGs)...

  • Screening for Cervical Cancer Using Automated Analysis of PAP-Smears. Bengtsson, Ewert; Malm, Patrik // Computational & Mathematical Methods in Medicine;2014, p1 

    Cervical cancer is one of the most deadly and common forms of cancer among women if no action is taken to prevent it, yet it is preventable through a simple screening test, the so-called PAP-smear. This is the most effective cancer prevention measure developed so far. But the visual examination...

  • Industry involvement and baseline assumptions of cost-effectiveness analyses: diagnostic accuracy of the Papanicolaou test. Polyzos, Nikolaos P.; Valachis, Antonis; Mauri, Davide; Ioannidis, John P. A. // CMAJ: Canadian Medical Association Journal;4/5/2011, Vol. 183 Issue 6, pE337 

    Background: Industry involvement has been associated with more favourable cost-effectiveness ratios in cost-effectiveness analyses, but the mechanisms for this association are unclear. We evaluated whether the assumed accuracy of the Papanicolaou (Pap) test was correlated with the features of...

  • Zone of suspicion. O'Neill, Anne-Marie // Time International (South Pacific Edition);4/24/95, Issue 16, p58 

    Discusses the advantages and disadvantages of the Pap smear procedure. Percentage of cervical cancers that can prevented using the method; Pre-cancerous changes known as Cervical Intraepithelial Neoplasia (CIN); Number of women in 10 who will receive a `false negative' result; Rise of cervical...

  • Study Finds No Advantage to Newer Tests for Cervical Cancer. Wang, Linda // JNCI: Journal of the National Cancer Institute;5/7/2003, Vol. 95 Issue 9, p644 

    Cites a study by researchers from the French Society of Clinical Cytology Study Group, which suggests that alternative tests do not outperform conventional testing and should not replace the Pap smear for cervical cancer screening. Comparison of the sensitivity, specificity, and reliability of...

  • New Tests for Cervical Cancer Screening. Nuovo, Jim; Melnikow, Joy; Howell, Lydia P. // American Family Physician;9/1/2001, Vol. 64 Issue 5, p780 

    The Papanicolaou (Pap) smear has been used to screen women for cervical cancer since1940. Recently, a number of new technologies have been developed to improve the detection of cervical cancer and its precursors. However, there is substantial controversy about whether the new tests offer...

  • Effect of health beliefs on delays in care for abnormal cervical cytology in a multi-ethnic population. Nelson, Karin; Geiger, Ann M.; Mangione, Carol M. // JGIM: Journal of General Internal Medicine;Sep2002, Vol. 17 Issue 9, p709 

    Context: Women from racial and ethnic minorities in the United States have higher rates of cervical cancer and present with later stage disease compared to whites. Delays in care for abnormal Papanicolaou (Pap) smears can lead to missed cases of cervical cancer or late-stage...

  • Cervical smears: Are the right women being examined? Brindle, Geoffrey; Wakefield, John; Yule, Robert // British Medical Journal;5/15/1976, Vol. 1 Issue 6019, p1196 

    Focuses on the purpose and the categories of cervical smear screening among women in Great Britain. Significance of cervical smear screening for treating conditions precursor to cancer; Evaluation on the number of findings requiring further investigation among younger symptomless women;...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics